Cory Wiegert
Cory Wiegert has been named Chief Executive Officer (CEO) of CancerLinQ LLC, a wholly owned nonprofit subsidiary of ASCO. Mr. Wiegert, a proven expert in building and successfully launching innovative technology solutions, began his new role on August 13, 2018, and is overseeing the continued expansion and implementation of the CancerLinQ® platform.
CancerLinQ is a big data initiative that collects and analyzes data from patients with cancer at practices nationwide, drawing from electronic health records to inform and improve the quality of cancer care. The effort has two major components: 1) the CancerLinQ quality improvement and data-sharing platform for oncology practices, and 2) CancerLinQ Discovery®, which provides access to high-quality, deidentified data sets derived from patient data to academic researchers, non-profit organizations, government agencies, industry, and others in the oncology community. The CancerLinQ database contains more than a million cancer patient records, making it one of the largest and most comprehensive data sets of its kind.
Richard L. Schilsky, MD, FACP, FSCT, FASCO
As CEO, Mr. Wiegert will be tasked with implementing ASCO’s vision and the priorities of CancerLinQ’s Board of Governors. This includes developing new solutions to help oncology practices improve the day-to-day care they provide their patients and continuing to serve CancerLinQ collaborators. Mr. Wiegert replaces Richard L. Schilsky, MD, FACP, FSCT, FASCO, who was serving as interim CEO of CancerLinQ. Dr. Schilsky will continue his role as ASCO’s Chief Medical Officer.
Mr. Wiegert has 20 years of experience conceiving, developing, and launching new software and data analytics products, including several roles with IBM Incorporated. In his most recent position as Vice President of Product Management for IBM Watson Health, he led the successful launch of major projects, including IBM’s first cloud-based offerings in health care and the creation of new solutions from the integration of several major acquisitions. Prior to joining IBM, Mr. Wiegert held positions with Sterling Commerce, Siebel Systems, Inc., Centura Software Corporation, and Safety-Kleen.
CancerLinQ and CancerLinQ Discovery are projects of CancerLinQ LLC. For more information on how to participate or partner with CancerLinQ, please visit CancerLinQ.org. ■
© 2018. American Society of Clinical Oncology. All rights reserved.
